General Information
Version
4.1
Revision date
2023-09-30
Product name
Mometasone Dry Powder Inhaler Formulation
1.2.1 Relevant identified uses
Pharmaceutical
supplier name
Organon & Co
Emergency telephone
1-551-430-6000, 1-215-631-6999
Icons in SDS
Company Information
company name
Organon & Co
e-mail address of the competent person responsible for the Safety Data Sheet
EHSSTEWARD@organon.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360Df, H373
Hazard statements
Code
Statements
H360Df
May damage the unborn child; Suspected of damaging fertility
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
in accordance with the Hazardous Products Regulations Reproductive toxicity : Category 1B Specific target organ toxicity : Category 2 (Immune system, Liver, Kidney, Skin) - repeated exposure (Inhalation)
Signal word
Danger
Hazard statements
H360Df May damage the unborn child. Suspected of damaging fertility. H373 May cause damage to organs (Immune system, Liver, Kidney, Skin) through prolonged or repeated exposure if in- haled.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P280 Wear protective gloves, protective clothing, eye protection and face protection.
Response
P308 + P313 IF exposed or concerned: Get medical attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents and container to an approved waste disposal plant.
2.3 Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means.
